Why do doctors spend so long running clinical trials?
10 years of med school, then 200 hours on one report | Zygital8
Why do doctors spend so long running clinical trials?
10 years of med school, then 200 hours on one report | Zygital8
Bringing a new drug to market takes years of complex operational work.
According to McKinsey, AI has cut development timelines by six months per asset on average.
And 12 months saved can add more than $400 million in net present value across a sponsor's portfolio.
What makes AI-driven site selection more accurate than traditional trial planning?
Sponsors often select clinical trial sites based on geography or target indication, using limited and outdated sponsor or Contract Research Organization data.
As a result, 10 to 30% of activated sites fail to enroll any patients, while top-enrolling sites outperform median sites by 2 to 4 times.
Machine learning models address this gap by analyzing protocols, historical trials with similar end points, and site-level metrics such as activation timelines and Principal Investogator experience. This approach improves the identification of top-enrolling sites by 30% to 50% and accelerates enrollment by 10% to 15% or more.
How can an AI copilot help clinical trial managers prioritize what matters?
Top organizations centralize trial data in a "clinical control tower," a dashboard tracking milestones, site activation, enrollment, drug supply, and costs. Yet clinical trial managers must monitor thousands of data points daily, and control towers capture only 70% to 80% of the critical insights needed for active trial oversight.
A gen AI trial performance copilot prioritizes critical issues and executes specific actions, such as drafting targeted emails to sites based on historical performance and principal investigator preferences. Over time, the copilot learns which interventions succeed in which contexts, becoming an increasingly effective guide for the trial manager.
How can gen AI cut the time it takes to write a clinical study report?
Clinical Study Reports summarize trial results and often sit on the critical path to regulatory dossier completion. They typically span hundreds of pages and take medical writers eight to 14 weeks to draft and refine. Generative AI tools produce a 1st-draft within minutes from the protocol, the statistical analysis plan, and tables, listings, and figures. McKinsey reports that this accelerates CSR timelines by 40%, cutting the process to five to eight weeks, with 98% accuracy or more. One company reduced its 1st-draft timeline from 3 weeks to 3 days, halving the touch time from 200 hours to 100 hours. Medical writers can then focus on clinical insights instead of manual, repetitive tasks.
The final take: buy it, use it, break it, fix it, trash it, change it, mail it, upgrade it. Technologic*.
Okay, so the robot now writes the first draft, but that's only thanks to doctors who trained it to make it possible. Then they can indeed focus on what their 10 years of med school were for: reading the results, spotting what looks odd, deciding what it means for the patients in the trial, and signing off on the final report.
For hospitals and pharma teams, that means a 1st draft in 3 days instead of 3 weeks, a report in 5 to 8 weeks instead of 8 to 14, and 6 months saved per drug on average. Fewer weeks waiting, more weeks for the molecule to reach the people who need it.
*Last but not least: this has no link whatsoever with the article, but Daft Punk is stuck in my head, so let's end this one on a musical note. Press play and enjoy ↗